You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-680-ESGO Safety and efficacy of MORAb-202 in patients with platinum-resistant ovarian cancer: results from the expansion part of a phase 1 trial in Japan

Article metrics

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-680-ESGO Safety and efficacy of MORAb-202 in patients with platinum-resistant ovarian cancer: results from the expansion part of a phase 1 trial in Japan
Free

 

Online download statistics by month:

Online download statistics by month: October 2022 to October 2024

AbstractFullPdf
Oct 2022802
Nov 20222404
Dec 202280015
Jan 202351010
Feb 202363015
Mar 20236105
Apr 20238708
May 202366010
Jun 20235806
Jul 202374020
Aug 202380015
Sep 202360010
Oct 2023116014
Nov 2023131013
Dec 202365012
Jan 20247205
Feb 202492014
Mar 202483021
Apr 202453027
May 202432014
Jun 202440012
Jul 2024102022
Aug 202450025
Sep 202442015
Oct 20241201
Total16020315